What is Roundtable 100?

Roundtable 100 is the weekly power ranking of the top 100 investable tech growth assets spanning crypto tokens, AI companies, and next-gen public markets. Rankings are published every Friday after market close and guided by a blue-ribbon committee of industry experts.

What assets are included in the Roundtable 100?

The Roundtable 100 includes crypto tokens, public tech stocks with growth potential, and mining companies. It excludes legacy or slow-growth companies, private companies, and non-liquid investments.

How are Roundtable 100 rankings scored?

Assets are scored across five dimensions: Safety (1x), Liquidity (1x), Leadership (1x), Innovation (1x), and Growth (2x double-weighted). Growth is intentionally double-weighted to reflect the mandate of identifying future dominance rather than present size.

What is the Roundtable 100 investment thesis?

The Roundtable 100 focuses on long-term growth across public equities and cryptocurrencies with a 5+ year time horizon, investing in future-defining technologies and the critical systems that enable them — prioritizing assets that function as rails, bottlenecks, and structural constraints within emerging digital and industrial ecosystems.

Where AI actually delivers in drug discovery with Dave Hallett

Name: Where AI actually delivers in drug discovery with Dave Hallett
Uploaded: 2026-09-10T20:35:56.935Z
Duration: 1 min 17 s
Channel: Recursion
Description: Recursion CSO Dave Hallett joins Patrick Short on The Genetics Podcast to explore how AI is truly reshaping drug development – and its limitations.

Recursion

Sep 10, 2026

Partner

Recursion CSO Dave Hallett joins Patrick Short on The Genetics Podcast to explore how AI is truly reshaping drug development – and its limitations.Read full article

Comments

Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy